期刊文献+

非小细胞肺癌中FHIT基因及HER_2表达的意义及相关性研究

The significance and relationship between the expressions of FHIT gene and HER_2 in non-small cell lung cancer
原文传递
导出
摘要 目的探讨在非小细胞肺癌中脆性组氨酸三联体(FHIT)基因及人类表皮生长因子受体2(HER2)表达与临床病理的关系,以及二者在非小细胞肺癌中的相关性。方法用免疫组化法检测50例肺癌组织及21例癌旁非肺癌组织的FHIT基因及HER2阳性表达率。结果肺癌组织中FHIT蛋白表达阳性率为30.00%,显著低于非肺癌组织的80.95%(P<0.05),而且FHIT基因的表达与组织类型、淋巴结转移、TNM临床分期有关。肺癌中存在HER2的过度表达,表达率为56.00%,并与淋巴结转移、TNM分期相关。FHIT基因的表达与HER2存在负相关关系,相关系数(r)=-0.38。结论在肺癌的发生、浸润、转移病变阶段中存在FHIT的表达下调和HER2的过度表达,二者呈负相关。 Objective To examine the expressions of FHIT gene and HEP~ in non - small cell lung cancer(NSCLC)and the relationship between the expressions and the clinieopathological features of NSCLC, and to investigate the relationship between FHIT protein and HER2 expression. Methods FHIT protein and HEP2 expressions in 50 lung cancer cases and 21 adjacent non - cancer tissues were performed by immunohistochemistry. And the positive rates of FHIT and HER2 were measured. Results The positive rates of FHIT protein were 30.00% in lung cancer tissues. The expression levels of FHIT were significandy lower in lung cancer tissues than that in non - cancer lung tissues ( P 〈 0. 005 ) compared with 80.95% in non - cancer lung tissues. The relationships between the expression and histological types, metastatichilar lymphnodes,TNM clinical stage. HER2 were over - expressed in lung cancer in 56.00%. The over - expression of HER2 correlates with the lymph node metastasis, TNM staging. An inverse correlation was found between FHIT protein expression and over - express HER2 ( r = - 0. 38, P 〈 0.05 ). Conclusions These data indicate that reduction of FHIT gene expression and over - expressed HER2 are frequent in lung cancer. An inverse correlation was found between FHIT protein expression and over - expressed HER2. They may be play an important role in the progression and metastasis of lung carcinoma.
出处 《中国医师进修杂志》 2006年第11期14-16,共3页 Chinese Journal of Postgraduates of Medicine
基金 遵义市科研基金资助项目(遵市科合2004)
关键词 脆性组氨酸三联体 人类表皮生长因子受体2 肿瘤 Fragile htstidine traid gene Human epidermal - growth - factor receptor 2 Carcinoma Lung
  • 相关文献

参考文献9

  • 1Ohta M,Inoue H,Cotticelli MG,et al.The FHIT gene,spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t (3;8) breakpoint,is abnormal in digestive tract cancer.Cell,1996,84(2):587-597.
  • 2李立,安倩,冯晓莉,张建军,黄进丰,刘乐尧,程书钧,高燕宁.肺癌组织3号染色体短臂上抑癌基因异常改变的初步分析[J].中华医学杂志,2001,81(7):399-401. 被引量:14
  • 3Deng YF,Tian F,Lu YD.Mutation and abnormal expression of the fragile histidine triad gene in nasopharyngeal carcinoma.Laryngoscope,2001,111(9):1589-1592.
  • 4Sozzi G,Sard L,De Gregorio L,et al.Association between cigarette smoking and FHIT gene alterations in lung cancer.Cancer Res,1997,57(11):2121-2123.
  • 5Jacobs TW,Gown AM,Yaziji H,et al.Sepecificity of Hercep Test in determing HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system.J Clin Oncol,1999,17(7):1983-1987.
  • 6Zochbauer-Muller S,Fong KM,Maitra A,et al.5'CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer.Cancer Res,2001,61(9):3581-3585.
  • 7Geradts J,Fong KM,Zimmerman PV,et al.Loss of FHIT expression in non-small-cell lung cancer:correlation with molecular genetic abnormalities and clinicopathological features.Br J Cancer,2000,82(6):1191-1197.
  • 8邓在春,葛棣,张敦华,谭云山,白春学,徐永华.人表皮生长因子受体家族在肺癌中的表达研究[J].中华结核和呼吸杂志,2002,25(4):207-209. 被引量:12
  • 9Tsai CM,Chang KT,Perng RP,et al.Correlation of intrinsic chemoresistance of non-small-cell lung cancer cell lines with HER-2/neu gene expression but not with ras gene mutations.J Natal Cancer Inst,1993,85(11):897-901.

二级参考文献11

  • 1陈杰 刘彤华 等.人肺癌细胞中生长因子的自泌循环和癌基因表达[J].中华病理学杂志,1995,24:25-28.
  • 2Sozzi G,Sard L,De Gregorio L,et al.Association between cigarette smoking and FHIT gene alterations in lung cancer[].Cancer Research.1997
  • 3Reed AL,Califano J,Cairns P,et al.High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma[].Cancer Research.1996
  • 4Croce CM,Sozzi G,Huebner K.Role of FHIT in human cancer[].Journal of Clinical Oncology.1999
  • 5Califano J,Van Der Riet P,Westra W,et al.Genetic progression model for head and neck cancer: implication for field cancerization[].Cancer Research.1996
  • 6Inoue H,Ishii H,Alder H,et al.Sequence of the FRA3B common fragile region: implications for the mechanism of FHIT deletion[].Proceedings of the National Academy of Sciences of the United States of America.1997
  • 7Nelson HH,Wiencke JK,Gunn L,et al.Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos[].Cancer Research.1998
  • 8Benachenhou N,Guiral S,Gorska Flipot I,et al.High resolution deletion mapping reveals frequent allelic losses at the DNA mismatch repair loci hMLH1 and hMSH3 in non-small cell lung cancer[].International Journal of Cancer.1998
  • 9Latif F,Tory K,Gnarra J,et al.Identification of the von Hippel-Lindau disease tumor suppressor gene[].Science.1993
  • 10Pace HC,Garrison PN,Robinson AK,et al.Genetic, biochemical,and crystallographic characterization of Fhit-substrate complexes as the active signaling form of Fhit[].Proceedings of the National Academy of Sciences of the United States of America.1998

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部